Abdominal Obesity Clinical Trials

9 recruiting

Abdominal Obesity Trials at a Glance

8 actively recruiting trials for abdominal obesity are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 6 trials, with the heaviest enrollment activity in Aurora, Beijing, and Boston. Lead sponsors running abdominal obesity studies include François Lellouche, Guang'anmen Hospital of China Academy of Chinese Medical Sciences, and Centre Hospitalier Universitaire Dijon.

Browse abdominal obesity trials by phase

Treatments under study

About Abdominal Obesity Clinical Trials

Looking for clinical trials for Abdominal Obesity? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Abdominal Obesity trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Abdominal Obesity clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Not Applicable

Effect of Electrical Stimulation and Exercise on Blood Flow in Patients With Resistant High Blood Pressure

Metabolic SyndromeAbdominal ObesityHigh Blood Pressure+5 more
Mohamed Mohamed Ali Morgan50 enrolled1 locationNCT07383220
Recruiting
Not Applicable

Evaluation of Exercise Capacity in Teenage Females Using Virtual Reality and Plyometric Workout

Abdominal Obesity
New Ismailia National University100 enrolled1 locationNCT07092228
Recruiting
Not Applicable

Influence of FreeO2 on Percentage of Time Within Oxygen Saturation Target Using Noninvasive Ventilation (NIV) and Continuous Positive Airway Pressure (CPAP) for Patients Admitted for AECOPD or Bariatric Surgery

SurgeryCOPD ExacerbationAbdominal Obesity+1 more
François Lellouche10 enrolled1 locationNCT04136717
Recruiting
Not Applicable

Acupuncture for Prediabetes With Combined Obesity

ObesityAbdominal Obesity
Guang'anmen Hospital of China Academy of Chinese Medical Sciences260 enrolled1 locationNCT06359418
Recruiting
Not Applicable

Culturally Adapted Dietary Clinical Trial in PR

ObesityHypertensionDiabetes Mellitus, Type 2+4 more
Harvard School of Public Health (HSPH)250 enrolled1 locationNCT05962372
Recruiting
Phase 2

Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV

FrailtyAgingHIV-1-infection+2 more
Massachusetts General Hospital100 enrolled2 locationsNCT06554717
Recruiting
Not Applicable

Translational Study Using Human Abdominal Adipose Tissue Biopsies to Investigate the Role of Cannabinoid Receptor 1 (CB1) in Controlling Endocannabinoid and Adipokine Secretion

Diabete Type 2Abdominal Obesity
Centre Hospitalier Universitaire Dijon45 enrolled1 locationNCT04940962
Recruiting
Phase 4

Metformin for Mind and Metabolism

DepressionAbdominal Obesity
The Alfred Hospital30 enrolled1 locationACTRN12613000856718